Abstract: A through pin assembly for securing an axle into a pair of mounting cheeks and to stabilize a machine member is disclosed. The pin assembly has an axle having a pair of end members formed on each end of the axle. A channel is formed through the axle and runs a length of the axle. The channel consists of a threaded area of the channel at the first end for use when removing the assembly; a hexagon, octagon or otherwise shaped area at the second end to interlock with the threaded part of the locking end member; two grooves in the channel, one at each end, as a seat for gaskets to seal off a grease or oil chamber for distribution to the bearing. A bearing is mounted on a central section of the axle. A pair of expansion sleeves is provided wherein one of the pair of expansion sleeves is positioned over each of the end member of the axle. A locking device is inserted into the channel.

Abstract: The invention provides a process for treating a loaded solvent stream having a time-varying contaminant concentration, the process comprising the steps of: (a) providing a plurality of hold-up tanks; (b) feeding the loaded solvent stream in dependence on its contaminant concentration to one or more of the hold-up tanks and; (c) allowing lowed solvent to flow from the plurality of hold-up tanks to obtain a smoothed loaded solvent stream having a reduced time-varying contaminant concentration. The invention further provides a treating unit comprising a circuit for circulating a solvent stream, which circuit includes a device for smoothing contaminant peak concentrations, said device comprising a plurality of hold-up tanks each hold-up tank having at least one inlet and an outlet equipped with an outlet valve, the device further comprising an inlet distributor allowing the control of solvent flow to one or more of the hold-up tanks.

Abstract: The present disclosure generally relates to enabling web applications to use application programming interfaces (APIs) to display content on a mobile computing device. In some embodiments, the APIs can include services to enable web applications to simulate a native application that runs natively on the mobile computing device. In some embodiments, the APIs can include services to annotate a map with an overlay on the display of the mobile computing device. In some embodiments, a caching module is provided for caching resources associated with a web application on the mobile computing device.

Abstract: There is provided homogeneous pharmaceutical compositions for the treatment of inflammatory disorders comprising an antiinflammatory and/or antihistaminic active ingredient, a polar lipid liposome and a pharmaceutically-acceptable aqueous carrier.

Abstract: Device for registration of temperature over an area by means of thermochromatic materials, which includes one, two or several layers (1, 3) with thermochromatical material, and one or several surrounding heat storing plastic layers (4, 6) that extend the reading time with maintained heat picture. In the case with several thermochromatic layers these preferably are of different termocromatical materials reacting at different temperatures and so chosen and so arranged that the termocromatic materials together constitute a scale of temperature areas. By means of a template the colors in the termocromatic layers can be interpreted to temperatures or temperature intervals and be noted.

Abstract: A pin assembly for providing a stable anchor on multiple ends has an axle having a pair of end members formed on each end of the axle. The axle is placed in a first opening in a first mounting end of a component part and extends to a second opening in a second mounting end of the component part. A bearing is mounted on a central section of the axle. A spacer is positioned between the bearing and one of the first or second mounting ends. A pair of expansion sleeves is provided wherein one of the pair of expansion sleeves is positioned over each of the end members of the axle. A pair of locking devices is provided wherein one of the pair of locking devices is coupled to each of the end members. When tightened, the locking devices cause the expansion sleeves to press against interior walls of the first and second openings to anchor the axle.

Abstract: The present invention provides a pharmaceutical composition for the sustained release of C-peptide. The composition is in the form of a gel containing C-peptide. The gel formation is achieved by the adjustment of pH of the composition and/or by addition of divalent metal ions. The composition does not include any other gel-forming agents. Methods for producing the composition, medical uses of the composition and products containing two or more gel compositions as a combined preparation are also encompassed.

Abstract: Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.

Abstract: The invention provides a process for removing mercaptans from a gas stream comprising natural gas or inert gas and mercaptans, the process comprising the steps of: (a) contacting a first gas stream comprising natural gas or inert gas and mercaptans with a hydrodesulphurisation catalyst in the presence of hydrogen in a hydrodesulphurisation unit to obtain a second gas stream comprising natural gas or inert gas, which is depleted of mercaptans and enriched in H2S; (b) removing H2S from the second gas stream comprising natural gas or inert gas in a H2S removal unit to obtain a purified gas stream comprising natural gas or inert gas, which is depleted of mercaptans.

Abstract: The invention provides a method for disposal of di-sulphide compounds, the method comprising the steps of: (a) combusting di-sulphide compounds at elevated temperature in the presence of an oxygen-containing gas in a sulphur dioxide generation zone, whereby at least part of the di-sulphide compounds is converted to sulphur dioxide to obtain a gas stream comprising sulphur dioxide; (b) reacting the gas stream comprising sulphur dioxide with hydrogen sulphide to obtain elemental sulphur.

Abstract: Use of the antimicrobial cathelicidin peptide ll-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithalial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.

Abstract: The invention provides a process for treating a loaded solvent stream having a time-varying contaminant concentration, the process comprising the steps of: (a) providing a plurality of hold-up tanks; (h) feeding the loaded solvent stream in dependence on its contaminant concentration to one or more of the hold-up tanks and; (c) allowing lowed solvent to flow from the plurality of hold-up tanks to obtain a smoothed loaded solvent stream having a reduced time-varying contaminant concentration. The invention further provides a treating unit comprising a circuit for circulating a solvent stream, which circuit includes a device for smoothing contaminant peak concentrations, said device comprising a plurality of hold-up tanks each hold-up tank having at least one inlet and an outlet equipped with an outlet valve, the device further comprising an inlet distributor allowing the control of solvent flow to one or more of the hold-up tanks.

Abstract: The invention relates to colloidal aqueous solutions of complexes between a charged peptide and a bilayer-forming galactolipid. The colloidal solutions can be used as a drug delivery system for the charged peptide in the treatment of infections, in wound healing and in other diseases.

Abstract: A viscous or gellous pharmaceutical composition for the treatment of constipation by rectal administration comprises a polar lipid component, a polyvalent alcohol component, water, and optionally an oily triglyceride. Also disclosed is a compressible device filled with a single dose of the composition and a method for its manufacture; a method of treating constipation, comprising rectal administration of a constipation-dissolving amount of the composition; and a method of manufacture of a medicament for treating constipation comprising the composition of the invention.

Abstract: A topical formulation of the oil-in-water type comprising an oily material, an aqueous phase and an emulsifier, wherein the emulsifier is a galactolipid material, as a carrier for providing a reduced irritant effect of an incorporated active substance on the skin. New topical formulations are also described.

Abstract: A device for measuring or visualizing temperature distribution along a line or an area, said device comprising areas of relatively good heat conducting or heat storing properties alternating with heat insulating or poorly heat storing areas, so that when the device is brought in contact with an object to be measured more heat energy is transferred to the heat absorbing or heat storing areas than to the heat insulating areas so that heat equalizing does not take place between the heat conducting or heat storing areas for a time, whereupon the temperature remains stable for a time.

Abstract: Use of the antimicrobial cathelicidin peptide ll-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithalial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.

Abstract: There is provided pharmaceutical compositions for the treatment of rhinitis by, for example, nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutical-acceptable aqueous carrier. The compositions are preferably homogeneous in their nature.

Abstract: A pharmaceutical composition for the treatment of rhinitis by nasal or ocular administration comprises zwitterionic cetirizine, polar lipid liposome, a pharmaceutical acceptable aqueous carrier and, optionally, a pharmaceutically acceptable buffer capable of providing a pH of from pH 4.0 to pH 8.0, with the proviso that, if the polar lipid comprises phospholipid, the amount of phospholipid in the composition from is from 10 mg per mL to 120 mg per mL. Also disclosed are methods for its preparation and methods for treating rhinitis by its nasal or ocular administration.

Abstract: The present invention relates to the use of an enzyme mixture containing at least one enzyme with phospholipid:diacylglycerol acyltransferase activity for the production of plant storage lipids containing polyunsaturated fatty acids.